Arecor Therapeutics plc (LON:AREC – Get Free Report) fell 1.3% during mid-day trading on Tuesday . The company traded as low as GBX 74 ($0.92) and last traded at GBX 74 ($0.92). 204 shares traded hands during trading, a decline of 90% from the average session volume of 2,132 shares. The stock had previously closed at GBX 75 ($0.94).
Arecor Therapeutics Price Performance
The firm’s 50-day moving average is GBX 73.68 and its 200-day moving average is GBX 82.07. The company has a quick ratio of 6.24, a current ratio of 1.37 and a debt-to-equity ratio of 5.51. The company has a market capitalization of £27.94 million, a PE ratio of -264.29 and a beta of -0.18.
About Arecor Therapeutics
Arecor Therapeutics plc is a biopharmaceutical company transforming patient care by bringing innovative medicines to market. Through the enhancement of existing medicines using our Arestat™ technology, we are developing a broad portfolio of therapies as part of our proprietary pipeline and through partnerships with leading pharmaceutical and biotech companies.
See Also
- Five stocks we like better than Arecor Therapeutics
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Which Wall Street Analysts are the Most Accurate?
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- What is a SEC Filing?
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
